141 related articles for article (PubMed ID: 12369890)
1. Complexities of glucuronidation affecting in vitro in vivo extrapolation.
Lin JH; Wong BK
Curr Drug Metab; 2002 Dec; 3(6):623-46. PubMed ID: 12369890
[TBL] [Abstract][Full Text] [Related]
2. Enzyme Kinetics of Uridine Diphosphate Glucuronosyltransferases (UGTs).
Zhou J; Argikar UA; Miners JO
Methods Mol Biol; 2021; 2342():301-338. PubMed ID: 34272700
[TBL] [Abstract][Full Text] [Related]
3. SLC35B1 significantly contributes to the uptake of UDPGA into the endoplasmic reticulum for glucuronidation catalyzed by UDP-glucuronosyltransferases.
Ondo K; Arakawa H; Nakano M; Fukami T; Nakajima M
Biochem Pharmacol; 2020 May; 175():113916. PubMed ID: 32179043
[TBL] [Abstract][Full Text] [Related]
4. Molecular and functional characterization of microsomal UDP-glucuronic acid uptake by members of the nucleotide sugar transporter (NST) family.
Kobayashi T; Sleeman JE; Coughtrie MW; Burchell B
Biochem J; 2006 Dec; 400(2):281-9. PubMed ID: 16965264
[TBL] [Abstract][Full Text] [Related]
5. Carrier-mediated transport of uridine diphosphoglucuronic acid across the endoplasmic reticulum membrane is a prerequisite for UDP-glucuronosyltransferase activity in rat liver.
Bossuyt X; Blanckaert N
Biochem J; 1997 May; 323 ( Pt 3)(Pt 3):645-8. PubMed ID: 9169596
[TBL] [Abstract][Full Text] [Related]
6. Optimization of Experimental Conditions of Automated Glucuronidation Assays in Human Liver Microsomes Using a Cocktail Approach and Ultra-High Performance Liquid Chromatography-Tandem Mass Spectrometry.
Badée J; Qiu N; Parrott N; Collier AC; Schmidt S; Fowler S
Drug Metab Dispos; 2019 Feb; 47(2):124-134. PubMed ID: 30478159
[TBL] [Abstract][Full Text] [Related]
7. Identification of human UDP-glucuronosyltransferase responsible for the glucuronidation of niflumic acid in human liver.
Mano Y; Usui T; Kamimura H
Pharm Res; 2006 Jul; 23(7):1502-8. PubMed ID: 16783480
[TBL] [Abstract][Full Text] [Related]
8. Enzyme kinetics of uridine diphosphate glucuronosyltransferases (UGTs).
Zhou J; Miners JO
Methods Mol Biol; 2014; 1113():203-28. PubMed ID: 24523115
[TBL] [Abstract][Full Text] [Related]
9. The effects of UDP-sugars, UDP and Mg
Walia G; Smith AD; Riches Z; Collier AC; Coughtrie MWH
Xenobiotica; 2018 Sep; 48(9):882-890. PubMed ID: 28868965
[TBL] [Abstract][Full Text] [Related]
10. Human placental glucuronidation and transport of 3'azido-3'-deoxythymidine and uridine diphosphate glucuronic acid.
Collier AC; Keelan JA; Van Zijl PE; Paxton JW; Mitchell MD; Tingle MD
Drug Metab Dispos; 2004 Aug; 32(8):813-20. PubMed ID: 15258106
[TBL] [Abstract][Full Text] [Related]
11. [Investigation of metabolic kinetics and reaction phenotyping of ligustrazin by using liver microsomes and recombinant human enzymes].
Tan Y; Zhuang XM; Shen GL; Li H; Gao Y
Yao Xue Xue Bao; 2014 Mar; 49(3):374-9. PubMed ID: 24961110
[TBL] [Abstract][Full Text] [Related]
12. Characterisation of UDP-glucuronosyltransferase activity in sea turtle
Dias VHV; Mattos JJ; Bastolla CLV; Lüchmann KH; Bainy ACD
Xenobiotica; 2022 Dec; 52(12):1011-1019. PubMed ID: 36594659
[TBL] [Abstract][Full Text] [Related]
13. Identification and characterization of oxymetazoline glucuronidation in human liver microsomes: evidence for the involvement of UGT1A9.
Mahajan MK; Uttamsingh V; Gan LS; Leduc B; Williams DA
J Pharm Sci; 2011 Feb; 100(2):784-93. PubMed ID: 20669329
[TBL] [Abstract][Full Text] [Related]
14. Quantitative Characterization of Major Hepatic UDP-Glucuronosyltransferase Enzymes in Human Liver Microsomes: Comparison of Two Proteomic Methods and Correlation with Catalytic Activity.
Achour B; Dantonio A; Niosi M; Novak JJ; Fallon JK; Barber J; Smith PC; Rostami-Hodjegan A; Goosen TC
Drug Metab Dispos; 2017 Oct; 45(10):1102-1112. PubMed ID: 28768682
[TBL] [Abstract][Full Text] [Related]
15. Evidence that unsaturated fatty acids are potent inhibitors of renal UDP-glucuronosyltransferases (UGT): kinetic studies using human kidney cortical microsomes and recombinant UGT1A9 and UGT2B7.
Tsoutsikos P; Miners JO; Stapleton A; Thomas A; Sallustio BC; Knights KM
Biochem Pharmacol; 2004 Jan; 67(1):191-9. PubMed ID: 14667942
[TBL] [Abstract][Full Text] [Related]
16. Structure and function of uridine diphosphate glucuronosyltransferases.
Meech R; Mackenzie PI
Clin Exp Pharmacol Physiol; 1997 Dec; 24(12):907-15. PubMed ID: 9406655
[TBL] [Abstract][Full Text] [Related]
17. Regioselective glucuronidation of denopamine: marked species differences and identification of human udp-glucuronosyltransferase isoform.
Kaji H; Kume T
Drug Metab Dispos; 2005 Mar; 33(3):403-12. PubMed ID: 15608137
[TBL] [Abstract][Full Text] [Related]
18. Altered AZT (3'-azido-3'-deoxythymidine) glucuronidation kinetics in liver microsomes as an explanation for underprediction of in vivo clearance: comparison to hepatocytes and effect of incubation environment.
Engtrakul JJ; Foti RS; Strelevitz TJ; Fisher MB
Drug Metab Dispos; 2005 Nov; 33(11):1621-7. PubMed ID: 16049128
[TBL] [Abstract][Full Text] [Related]
19. In vitro-in vivo correlation for drugs and other compounds eliminated by glucuronidation in humans: pitfalls and promises.
Miners JO; Knights KM; Houston JB; Mackenzie PI
Biochem Pharmacol; 2006 May; 71(11):1531-9. PubMed ID: 16455060
[TBL] [Abstract][Full Text] [Related]
20. Optimized assays for human UDP-glucuronosyltransferase (UGT) activities: altered alamethicin concentration and utility to screen for UGT inhibitors.
Walsky RL; Bauman JN; Bourcier K; Giddens G; Lapham K; Negahban A; Ryder TF; Obach RS; Hyland R; Goosen TC
Drug Metab Dispos; 2012 May; 40(5):1051-65. PubMed ID: 22357286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
